Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALLURION TECHNOLOGIES

2.41
+0.09003.88%
Post-market: 2.410.00000.00%17:40 EDT
Volume:49.88K
Turnover:119.29K
Market Cap:17.97M
PE:-0.23
High:2.46
Open:2.33
Low:2.30
Close:2.32
Loading ...

Allurion Technologies Inc: Outlook 2025 Revenue About $30 Mln

THOMSON REUTERS
·
26 Mar

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Business Wire
·
26 Mar

Allurion Technologies Inc expected to post a loss of $5.17 a share - Earnings Preview

Reuters
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

Allurion Shares Surge 40% on Positive Results from Weight-Loss Study

Dow Jones
·
21 Mar

Allurion Technologies Price Target Maintained With a $16.00/Share by Roth MKM

Dow Jones
·
21 Mar

Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results

Benzinga
·
21 Mar

Allurion Technologies Shares Rise 66% on Initial Data From Weight-Loss Device Treatment

THOMSON REUTERS
·
21 Mar

Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak

MT Newswires Live
·
21 Mar

Investors Face Another Losing Week as US Futures Lower Slip Pre-Bell

MT Newswires Live
·
21 Mar

Allurion Technologies Is Maintained at Neutral by Chardan Capital

Dow Jones
·
21 Mar

Allurion Technologies Shares Rise 39.5% to $3.18 Premarket After Initial Data From Weight-Loss Device Treatment

THOMSON REUTERS
·
21 Mar

Allurion Technologies’ gastric balloon+GLP1s may become new SOC, says Roth MKM

TIPRANKS
·
21 Mar

Allurion Technologies Reports Positive Ballon Combination Study Results; Shares Jump

MT Newswires Live
·
21 Mar

BUZZ-Allurion Technologies rises on initial data from weight-loss device treatment

Reuters
·
21 Mar

Allurion announces initial results from Allurion Program-GLP-1 combo

TIPRANKS
·
21 Mar

Allurion Technologies Inc - Average Total Weight Loss of 20% With 15% Increase in Lean Body Mass After 8 Months of Combined Therapy

THOMSON REUTERS
·
21 Mar

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-Dose Glp-1 Therapy to Optimize Muscle Mass and Glp-1 Adherence

THOMSON REUTERS
·
21 Mar

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Business Wire
·
21 Mar